The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants

Vaccine

Volumn 14, Issue 9, 1996, Pages 905-909

  Mulholland, E Kim ^a   Hoestermann, Anne ^b   Ward, Joel I ^c   Maine, Nicholas ^d   Ethevenaux, Chantal ^e   Greenwood, Brian M ^f  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Harbor UCLA Medical Center ^*  (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e Hospices Civils de Lyon   (France)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Combined vaccine; Diphtheria tetanus pertussis vaccine; Haemophilus influenzae type b

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MENINGITIS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030174313     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00260-8     Document Type: Article

References (34)

1. 1 Bijlmer, H.A., Ellis, R.W. and Granoff, D.M. Development and Uses of Haemophilus b Conjugate Vaccines 1994, 247-264. Marcel Dekker, New York
2. 2 Bijlmer, H.A., van Alphen, L., Greenwood, B.M. et al. The epidemiology of Haemophilus influenzae meningitis in children under 5 years of age in The Gambia. West Africa. J. Infect. Dis. 1990, 161, 1210-1215
3. 3 Funkhouser, A., Steinhoff, M.C. and Ward, J. Haemophilus influenzae disease and immunization in developing countries. Rev. Infect. Dis. 1991, 13Suppl 6, S542-S554
4. 4 Tall, F.R., Elola, A., Prazuck, T. et al. Méningites à Haempohilus influenzae à Bobo-Dioulasso (Burkina Faso). Méd. Mal. Infect. 1992, 22, 1173-1177
5. 5 Eskola, J., Käyhty, H., Takala, A.K. et al. A randomized prospective trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 1990, 323, 1381-1387
6. 6 Santosham, M., Wolff, M., Reid, R. et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N. Engl. J. Med. 1991, 324, 1767-1772
7. 7 Eskola, J., Peltola, H., Takala, A.K. et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N. Engl. J. Med. 1987, 317, 717-722
8. 8 Black, S.B., Shinefield, H.R., Fireman, B. et al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61080 children. Pediatr. Infect. Dis. J. 1991, 10, 97-104
9. 9 Takala, A.K., Eskola, J., Leinonen, M. et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis. 1991, 164, 982-986
10. 10 Murphy, T.V., Pastor, P., Medley, F., Osterholm, M.T. and Granoff, D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 1993, 122, 517-523
11. 11 Takala, A.K., Santosham, M., Almeido-Hill, J. et al. Vaccination with Haemophiius influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr. Infect. Dis. J. 1993, 12, 593-599
12. 12 Adams, W.G., Deaver, K.A., Cochi, S.L et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. J. Am. Med. Assoc. 1993, 269, 221-226
13. 13 Mulholland, E.K., Byass, P., Campbell, H. et al. The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants. Ann. Trop. Paed. 1994, 14, 183-188
14. 14 Campbell, H., Byass, P., Ahonkhai, V.I., Vella, P.P. and Greenwood, B.M. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics 1990, 86, 102-107
15. 15 Mulholland, E.K., Todd, J., Rowe, M. et al. Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine. Ann. Trop. Paed. 1993, 13, 153-158
16. 16 Mulholland, E.K., Ahonkhai, V.l., Greenwood, A.M. et al. Safety and immunogenicity of Haemophilus influenzae type b-Neisseria meningitidis Group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. Pediatr. Infect. Dis. J. 1993, 12, 632-637
17. 17 Clemens, J.D., Ferrecio, C., Levine. M.M. et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. J. Am. Med. Assoc. 1992, 267, 673-678
18. 18 Avendano, A., Ferrecio, C., Lagos, R. et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serological response to diphtheria tetanus or pertussis antigens when co-administered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. J. 1993, 12, 638-643
19. 19 Byass, P., Hanlon, P.W., Hanlon, L.C.S., Marsh, V.M. and Greenwood, B.M. Microcomputer management of a vaccine trial. Comput. Biol. Med. 1988, 18, 179-193
20. 20 Farr, R.S. A quantitative immunochemical measure of the primary interaction between I*BSAand antibody. J. Infect. Dis. 1958, 103, 239-262
21. 21 Ward, J.I., Greenberg, D.P., Anderson, P.W. et al. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J. Clin. Microbiol. 1988, 26, 72-78
22. 22 Greenberg, D.P., Vadheim, C.M., Partridge, S. et al. Immunogenicity of Haemophilus influenzae type b polysaccharide toxoid conjugate vaccine in young infants. J. Infect. Dis. 1994, 170, 76-81
23. 23 Swan, A.V. Computing maximum likelihood estimates for parameters of the normal distribution from grouped and censored data Appl. Statist. 1969, 18, 65-69
24. 24 Wolynetz, M.S. Algorithm, A.S. 138: Maximum likelihood estimation from confined and censored normal data. Appl. Statist. 1979, 28, 185-194
25. 25 Dempster, A.P., Laird, N.M. and Rubin, D.B. Maximum likelihood from incomplete data via the EM algorithm. J. R. Statist. Soc. 1977, 39, 1-38
26. 26 Watemberg, N., Dagan, R., Arbelli, Y. et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr. Infect. Dis. J. 1991, 10, 758-761
27. 27 Ferreccio, C., Clemens, J., Avendano, A. et al. The clinical and immunological response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. J. 1991, 10, 764-771
28. 28 Kaplan, S.L., Ward, M.A., Lauer, B.L. et al. Immunogenicity and safety of H. influenzae type b-tetanus protein conjugate vaccine (PRP-T) alone or mixed with DTP in infants. American Pediatric Society/Society for Pediatric Research Abstract, May 1992
29. 29 Gold, R., Scheifele, D., Barreto, L. et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr. Infect. Dis. J. 1994, 13, 348-355
30. 30 Dagan, R., Botujansky, C., Watemberg, N. et al.Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated polio vaccine. Pediatr. Infect. Dis. J. 1994, 13, 356-361
31. 31 Scheifele, D., Baretto, L., Meekison, W., Guasparini, R. and Friesen, B. Can H. influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid, pertussis vaccine, tetanus toxoid? Can. Med. Assoc. J. 1993, 149, 1105-1111
32. 32 Paradiso, P. Combined childhood immunizations (letter). J. Am. Med. Assoc. 1992, 268, 1685
33. 33 Bass, J.W. and Wittler, R.R. Return of epidemic pertussis in the United States. Pediatr. Infect. Dis. J. 1994, 13, 343-345
34. 34 Mulholland, E.K. Measles and pertussis in developing countries with good vaccine coverage. Lancet 1995, 345, 305-307